Simultaneously, tumor necrosis factor-alpha suppresses erythroid progenitor differentiation in the bone marrow and diminishes erythropoietin responsiveness, further exacerbating anemia (De Simone et al., 2014). Here, EPO is linked to anemia (phenotype).